An observational study in NSCLC, sponsored by Shanghai Chest Hospital. Enrolling by invitation at 1 site in China. Per ClinicalTrials.gov, last updated 2024-11-13.
Sponsored by Shanghai Chest Hospital · Observational
This is an observational study evaluating the clinical characteristics, treatment patterns, and clinical outcomes of perioperative NSCLC patients receiving different treatment strategies. According to the inclusion and exclusion criteria, perioperative NSCLC patients admitted to the study center from January 1, 2020, to one year after the study initiation will be retrospectively screened and collected.
Shanghai Chest Hospital is the lead sponsor of 194 studies on the registry; 94 are open to participants now.
Counted across the registry records on this site, refreshed daily.
stage I-III NSCLC under different perioperative treatment
Exclusion Criteria:
event-free survival
the time from randomization to any progression of disease precluding surgery, progression or recurrence of disease after surgery, progression of disease in the absence of surgery, or death from any cause;
Time frame: From date of diagnosis until the date of first documented progression, recurrence or date of death from any cause, whichever came first, assessed up to 36 months
overall survival
from diagnosis to death
Time frame: From date of diagnosis until the date of death from any cause, whichever came first, assessed up to 60 months
R0 resection rate
margin negative resection
Time frame: usually 1 week after surgery
major pathological response
viable tumor cell less than 10%
Time frame: usually 1 week after surgery
p-CR
no viable tumor cells was observed
Time frame: usually 1 week after surgery
Plan to share: Undecided — we need to further analyze the data
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Chest Hospital